Columbus Macro LLC Has $649,000 Stock Position in iShares Biotechnology ETF $IBB

Columbus Macro LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 79.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,842 shares of the financial services provider’s stock after selling 14,983 shares during the quarter. Columbus Macro LLC’s holdings in iShares Biotechnology ETF were worth $649,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $25,000. Basepoint Wealth LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at $26,000. Cary Street Partners Financial LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at $29,000. Copia Wealth Management acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $34,000. Finally, Caitlin John LLC acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $34,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 2.0%

Shares of iShares Biotechnology ETF stock opened at $187.38 on Friday. iShares Biotechnology ETF has a one year low of $125.70 and a one year high of $188.69. The business has a 50-day simple moving average of $171.45 and a 200 day simple moving average of $171.03.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.